OncoStem Diagnostics is an Indian biotech startup focused on developing prognostic and predictive cancer diagnostic tests, with their flagship product CanAssist-Breast which helps determine whether breast cancer patients would benefit from chemotherapy or not in order to avoid overtreatment and improve quality of life by sparing unnecessary toxic chemotherapy for up to 55,000 women per year in India.